Happy to announce our support for Elevian together with BOLD Capital and Peter Diamandis.
Commercializing scientific breakthroughs from Elevian’s scientific co-founders.
Read more
Sep 11, 2018
Elevian Launches to Develop Regenerative Medicines for Age-Related Diseases
Posted by Michael Greve in categories: biotech/medical, life extension, Peter Diamandis
Comments are closed.